Clinical Briefs
Pembrolizumab Eligibility for TMB-High Solid Tumors
Traditional approval retains a narrow, tissue-agnostic indication for adults and children with previously treated, unresectable or metastatic TMB-high solid tumors and no satisfactory alternatives.
Rayan Salih · October 28, 2026 · 6 min